FY2023 Earnings Estimate for BridgeBio Pharma, Inc. (NASDAQ:BBIO) Issued By Leerink Partnrs
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Research analysts at Leerink Partnrs raised their FY2023 earnings estimates for BridgeBio Pharma in a report released on Wednesday, February 7th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($3.80) per share for the year, up from their previous forecast of […]
More Stories
SGI Enhanced Global Income ETF (NASDAQ:GINX) Sees Large Increase in Short Interest
SGI Enhanced Global Income ETF (NASDAQ:GINX – Get Free Report) was the recipient of a significant increase in short interest...
Aeva Technologies, Inc. (NYSE:AEVA) Short Interest Update
Aeva Technologies, Inc. (NYSE:AEVA – Get Free Report) was the recipient of a significant increase in short interest in the...
FS KKR Capital Corp. (NYSE:FSK) Short Interest Down 19.1% in October
FS KKR Capital Corp. (NYSE:FSK – Get Free Report) saw a large decrease in short interest in the month of...
Short Interest in First Trust Large Cap Core AlphaDEX Fund (NASDAQ:FEX) Declines By 21.6%
First Trust Large Cap Core AlphaDEX Fund (NASDAQ:FEX – Get Free Report) was the target of a significant drop in...
Domino’s Pizza, Inc. (NYSE:DPZ) Short Interest Update
Domino’s Pizza, Inc. (NYSE:DPZ – Get Free Report) saw a large increase in short interest in October. As of October...
Climb Global Solutions, Inc. (NASDAQ:CLMB) Short Interest Update
Climb Global Solutions, Inc. (NASDAQ:CLMB – Get Free Report) was the target of a significant increase in short interest during...